Daiwa Securities Group
DNLI icon

Daiwa Securities Group’s Denali Therapeutics DNLI Stock Holding History

Daiwa Securities Group’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-475
Closed -$8K – 1254
2025
Q4 		$8K Hold
475
– – ﹤0.01% 1199
2025
Q3 		$7K Hold
475
– – ﹤0.01% 1180
2025
Q2 		$7K Hold
475
– – ﹤0.01% 1133
2025
Q1 		$6K Hold
475
– – ﹤0.01% 1121
2024
Q4 		$10K Sell
475
-71
-13% -$1.82K ﹤0.01% 1118
2024
Q3 		$16K Hold
546
– – ﹤0.01% 1110
2024
Q2 		$13K Hold
546
– – ﹤0.01% 1152
2024
Q1 		$11K Hold
546
– – ﹤0.01% 1162
2023
Q4 		$12K Hold
546
– – ﹤0.01% 1159
2023
Q3 		$11K Hold
546
– – ﹤0.01% 1122
2023
Q2 		$16K Hold
546
– – ﹤0.01% 1113
2023
Q1 		$13K Hold
546
– – ﹤0.01% 1094
2022
Q4 		$15K Buy
546
+88
+19% +$2.62K ﹤0.01% 1089
2022
Q3 		$14K Hold
458
– – ﹤0.01% 1111
2022
Q2 		$13K Buy
458
+102
+29% +$2.67K ﹤0.01% 1133
2022
Q1 		$11K Hold
356
– – ﹤0.01% 1134
2021
Q4 		$16K Sell
356
-61
-15% -$2.89K ﹤0.01% 1128
2021
Q3 		$21K Buy
417
+177
+74% +$9.98K ﹤0.01% 1100
2021
Q2 		$19K Hold
240
– – ﹤0.01% 1020
2021
Q1 		$14K Buy
240
+14
+6% +$937 ﹤0.01% 1027
2020
Q4 		$19K Sell
226
-361
-61% -$21.8K ﹤0.01% 985
2020
Q3 		$21K Hold
587
– – ﹤0.01% 983
2020
Q2 		$10K Hold
587
– – ﹤0.01% 1067
2020
Q1 		$10K Buy
587
+45
+8% +$939 ﹤0.01% 1058
2019
Q4 		$9K Sell
542
-62
-10% -$1.03K ﹤0.01% 1072
2019
Q3 		$9K Hold
604
– – ﹤0.01% 1038
2019
Q2 		$13K Hold
604
– – ﹤0.01% 1041
2019
Q1 		$14K Sell
604
-161
-21% -$3.37K ﹤0.01% 1010
2018
Q4 		$16K Buy
+765
New +$13.9K ﹤0.01% 977

Other funds holding DNLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Daiwa Securities Group's DNLI Position: Q1 2026 in Review

Daiwa Securities Group sold out of Denali Therapeutics (DNLI) in Q1 2026, closing a stake of 475 shares — an estimated $8K sold.

Daiwa Securities Group first reported a position in DNLI in Q4 2018 and held it in 29 quarters. The position peaked at $21K in Q3 2021. 268 funds tracked by Wall St. Rank hold DNLI as of Q1 2026.

  • Daiwa Securities Group reported no remaining Denali Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 475 Denali Therapeutics shares in Q1 2026, an estimated $8K.
  • Daiwa Securities Group first reported a position in Denali Therapeutics in Q4 2018 and held it in 29 quarters.
  • Daiwa Securities Group's Denali Therapeutics position peaked at $21K in Q3 2021.
  • 268 funds tracked by Wall St. Rank held Denali Therapeutics as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.